clinical trial · NCT07081841
AB-1005 Long-Term Follow-up Study
AskBio Inc·—·enrolling by invitation·n = 132
Parkinson's DiseaseMultiple System Atrophy, Parkinson VariantObservation
brief summary
This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.
started
Sep 4, 2025
primary completion
Sep 30, 2037
completion
Mar 30, 2038
last updated
Oct 2, 2025
official title
Long-Term Safety and Efficacy Follow-up of AB-1005 Gene Transfer Study Participants With Parkinson's Disease or Multiple System Atrophy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol